EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

por Bakker, Daphne S., Ariens, Lieneke F. M., Giovannone, Barbara, Hijnen, DirkJan, Delemarre, Eveline M., Knol, Edward, Nierkens, Stefan, de Bruin‐Weller, Marjolein S., Thijs, Judith L., Drylewicz, Julia
Publicado 2020

Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study

por Bakker, Daphne S., ter Linde, José J. M., Amini, Mojtaba M., Ariëns, Lieneke F. M., van Luijk, Chantal M., de Bruin‐Weller, Marjolein S., Thijs, Judith L., Vercoulen, Yvonne, van Wijk, Femke
Publicado 2021

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

por ARIËNS, Lieneke F. M., BAKKER, Daphne S., SPEKHORST, Lotte S., VAN DER SCHAFT, Jorien, THIJS, Judith L., HAECK, Inge, FLINTERMAN, Annebeth E., KAMSTEEG, Marijke, SCHUTTELAAR, Marie L. A., DE BRUIN-WELLER, Marjolein S.
Publicado 2021

Two‐year drug survival of dupilumab in a large cohort of difficult‐to‐treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay re...

por Spekhorst, Lotte S., Ariëns, Lieneke F.M., van der Schaft, Jorien, Bakker, Daphne S, Kamsteeg, Marijke, Oosting, Albert J., de Ridder, Ilona, Sloeserwij, Annemiek, Romeijn, Geertruida L.E., de Graaf, Marlies, Haeck, Inge, Thijs, Judith L., Schuttelaar, Marie L.A., de Bruin‐Weller, Marjolein S.
Publicado 2020